Huntington National Bank’s Definium Therapeutics DFTX Stock Holding History

Huntington National Bank’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	4230
2026 Q1	$1	Hold	1	–	–	﹤0.01%	4081
2025 Q4	$1	Hold	1	–	–	﹤0.01%	3988
2025 Q3	$1	Hold	1	–	–	﹤0.01%	4015
2025 Q2	$1	Hold	1	–	–	﹤0.01%	4021
2025 Q1	$1	Hold	1	–	–	﹤0.01%	4035
2024 Q4	$1	Hold	1	–	–	﹤0.01%	4030
2024 Q3	$1	Hold	1	–	–	﹤0.01%	4024
2024 Q2	$1	Hold	1	–	–	﹤0.01%	3973
2024 Q1	$1	Hold	1	–	–	﹤0.01%	3842
2023 Q4	$1	Hold	1	–	–	﹤0.01%	3740
2023 Q3	$1	Hold	1	–	–	﹤0.01%	3711
2023 Q2	$1	Hold	1	–	–	﹤0.01%	3658
2023 Q1	$1	Hold	1	–	–	﹤0.01%	3529
2022 Q4	$1	Sell	1 -2,000	-100%	-$5.55K	﹤0.01%	3396
2022 Q3	$7K	Buy	2,001 +1	+0.1%	+$10	﹤0.01%	1631
2022 Q2	$19K	Hold	2,000	–	–	﹤0.01%	1356
2022 Q1	$33K	Hold	2,000	–	–	﹤0.01%	1194
2021 Q4	$41K	Sell	2,000 -2,000	-50%	-$63.8K	﹤0.01%	1138
2021 Q3	$140K	Hold	4,000	–	–	﹤0.01%	679
2021 Q2	$207K	Buy	+4,000	New	+$210K	﹤0.01%	614

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Huntington National Bank's DFTX Position: Q2 2026 in Review

Huntington National Bank held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4230.

Huntington National Bank first reported a position in DFTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $207K in Q2 2021. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Huntington National Bank held 1 share of Definium Therapeutics worth $1 as of Q2 2026.
Huntington National Bank left its Definium Therapeutics share count unchanged in Q2 2026.
Definium Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #4230 holding.
Huntington National Bank first reported a position in Definium Therapeutics in Q2 2021 and has held it in 21 quarters since.
Huntington National Bank's Definium Therapeutics position peaked at $207K in Q2 2021.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.